Most of what we work on is related to disease though nearly all of it is at the discovery stage (i.e. working out what’s going wrong). We have a collaboration with a pharmaceutical company that is pretty exciting focussed on identifying drug targets for a couple of neurological diseases.
The closest thing we have to the clinic right now is a project to use computational methods to classify the severity of breast cancers in patients to predict what the best form of treatment for them is. We hope to develop this into a software product for the NHS and have recently secured funding to take the project to the pilot phase.
Comments